FDA delays ruling on Collegium's opioid painkiller 13.10.2015 00:17 Reuters (Reuters) - Collegium Pharmaceutical Inc said the U.S. Food and Drug Administration said it would not be able to complete its review of the company's opioid painkiller by Monday.
